User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
(→Lymphoma: + 'Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma ' at ncbi.nlm.nih.gov[1st seen in 1], a 2005 comparative study, published in w:FEBS Letters) |
(→Lymphoma: + 'Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma' at ncbi.nlm.nih.gov[1st seen in 1], a 2006 study, published in w:Molecular Pharmacology) |
||
| Line 389: | Line 389: | ||
== Lymphoma == | == Lymphoma == | ||
[[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia) | [[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia) | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/16936228 'Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2006''' study, published in [[w:Molecular Pharmacology]] | |||
* [http://www.ncbi.nlm.nih.gov/pubmed/16337199 'Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2005''' comparative study, published in [[w:FEBS Letters]] | * [http://www.ncbi.nlm.nih.gov/pubmed/16337199 'Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2005''' comparative study, published in [[w:FEBS Letters]] | ||